Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
We do not ship without a verified COA
doi: 10.3389/ftox.2024.1515850 Received 23 October 2024 Accepted 31 December 2024 Published 20 January 2025 Volume 6 - 2024 Edited by Yong Ho Kim, United States Environmental Protection Agency (EPA), United States Reviewed by Colette Miller, United States Environmental Protection Agency (EPA), United States Meghan Rebuli, University of North Carolina at Chapel Hill, United States Updates Copyright 2025 Granata, Morosini, Valerii, Fagiolino, Sangiorgi, Ghini, Spisni, Vivarelli, Fairclough, Paolini and Canistro
However, some RCTs in patients with clinical anxiety (e.g., GAD) did not find significant differences from placebo for primary anxiety endpoints, but did note improvements in sleep satisfaction
Due to the limited availability of early diagnostic techniques and the prevalence of chemotherapy resistance, the overall survival rate for individuals with advanced OC remains considerably low
US$ 21.92
US$ 29.96
US$ 29.73
US$ 23.96
US$ 28.08
US$ 23.80
US$ 29.95
US$ 28.81
